Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-02

Clinical Trial Update: Cortisol Diurnal Variation and the Risk for Developing Post Traumatic Stress Disorder

View source ↗

Summary

A clinical trial update examining whether diurnal cortisol variation is associated with the risk of developing post-traumatic stress disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheba Medical Center | Conditions: Posttraumatic Stress Disorders, Cortisol Diurnal Variation | Status: UNKNOWN